

Dr. Luis Madero Lopez is a distinguished figure in the field of Pediatric Hemato-Oncology, serving as the Chief of the Pediatric Hemato-Oncology Service at Quirón Salud Madrid University and the Oncohematology and Hematopoietic Transplant Service at Niño Jesús Hospital. With an impressive career spanning over 35 years, he holds the position of Professor of Pediatrics at the Autonomous University of Madrid, where he imparts his extensive knowledge and experience. Dr. Madero Lopez graduated in Medicine and Surgery from Complutense University in 1977 and further specialized in pediatrics, becoming a pediatric specialist at the same institute in 1984. Throughout his career, Dr. Madero has been a trailblazer in the field, contributing significantly to research and education. He served as the Head of the Cancer Center and Hematopoietic Transplantation Section at Niño Jesús Hospital and continues to lead the Oncohematology and Hematopoietic Transplantation Service at the same institute. His leadership extends to being the Chief of the Children's Hemato-Oncology Service at Quirónsalud Madrid Hospital. Dr. Luis Madero Lopez is recognized for his prolific contributions to scientific literature, with over 200 articles in global magazines, more than 200 in public magazines, and authoring over 12 books on pediatric Oncohematology. Additionally, he has participated in numerous national and international conferences, cementing his position as a respected authority in the field. His dedication to research is evident through his involvement in over 10 subsidized national research projects and collaboration in more than 20 research initiatives.
Dr. Luis Madero López is internationally respected for his comprehensive and research-driven approach to pediatric hemato-oncology and hematopoietic stem cell transplantation. His clinical philosophy emphasizes precision medicine, multidisciplinary collaboration, and long-term follow-up care for children with complex hematological and oncological conditions. Through decades of leadership, academic contribution, and groundbreaking research, he continues to shape pediatric cancer care and remains a trusted authority in the field in Spain and beyond.